Medpace Holdings: Despite Record Revenue, Order Intake Drags
Reading Time: 4 minutes
Medpace Holdings is a US-based contract research organization (CRO) that supports biotech, pharmaceutical, and medical device companies in conducting clinical trials. The company covers clinical development phases from Phase I to Phase IV and helps its clients efficiently navigate new drug and medical product studies, regulatory requirements, and approval processes. Medpace is particularly interesting because it is strongly science-oriented and positions itself as a full-service CRO, offering many steps of clinical research in one place. As a result,...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.

